ArticleFrontiers in immunology2020

Selective Janus Kinase 1 Inhibition Is a Promising Therapeutic Approach for Lupus Erythematosus Skin Lesions.

Tanja Fetter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.